BIBLIOGRAFÍA

En esta sección figuran las publicaciones más destacadas que abordan algún aspecto referente a la clínica, investigación, discapacidad o incapacidad de la Sensibilidad Química Múltiple (SQM). Esta recopilación ha sido seleccionada por el equipo de expertos que forman parte del Comité Científico de CONFESQ.

AÑO 2023

• Documento para solicitar el reconocimiento de la SQM en la OMS. (2023). Fundación Alborada, CONFESQ.
• Jiménez Fernández F, Jiménez Martín PI. Sensibilidad química múltiple en una niña de 8 años. Seguimiento durante 6 años . Rev Pediatr Aten Primaria. 2023;25 [en prensa].
• Hempel S, Danz M, Robinson KA, Bolshakova M, Rodriguez J, Mears A, Pham C, Yagyu S, Motala A, Tolentino D, Akbari O, Johnston J.  2023. Multiple chemical sensitivity scoping review protocol: overview of research and MCS construct. 

AÑO 2022

• Suzuki K, Okamura M, Haruyama Y, Suzuki S, Shiina T, Kobashi G, Hirata K. 2022. Exploring the contributing factors to multiple chemical sensitivity in patients with migraine. 

AÑO 2021

• A, Pokorski. M,  Di Giulio. C; “Volatile organic compounds (VOCs) in exhaled breath as a marker of hypoxia in multiple chemical sensitivity”. Physiol Rep 2021 Sep;9(18):e15034.
• Damian, M. Alessandrini, D. Caccamo, A. Cormano, G. Guzzi, A.Mazzatenta, A. Micarelli, A. Migliore, A.Piroli, M. Bianca, O. Tapparo and P. Pigatto. “Italian Expert Consensus on Clinical and Therapeutic anagement of Multiple Chemical Sensitivity (MCS)”. International Journal of Environmental Research and Public Health. 2021 Oct 27;18(21):11294.

AÑO 2020

• Greco F. (2020). “Technical Assessment of Ultrasonic Cerebral Tomosphygmography and New Scientific Evaluation of Its Clinical Interest for the Diagnosis of Electrohypersensitivity and Multiple Chemical Sensitivity”. Diagnostics (Basel, Switzerland), 10(6), 427.

AÑO 2019

• Steinemann, A. (2019). “Chemical sensitivity, asthma, and effects from fragranced consumer products: national population study in Sweden”. Air Quality, Atmosphere & Health. 2019, Volume 12, Issue 2, pp 129–136.
• Steinemann, A. (2019). “Chemical sensitivity, asthma, and effects from fragranced consumer products: National Population Study in the United Kingdom”. Air Quality, Atmosphere & Health. 2019, Volume 12, Issue 4, pp 371–377.
• Stojsavljević, A., Rovčanin, B., Krstić, Đ., Borković-Mitić, S., Paunović, I., Kodranov, I., Gavrović-Jankulović, M., & Manojlović, D. (2019). “Evaluation of trace metals in thyroid tissues: Comparative analysis with benign and malignant thyroid diseases”. Ecotoxicology and environmental safety, 183, 109479.
• Alameda Cuesta, A., Pazos Garciandia, A., Losa Iglesias, M.E. (2019). Fibromyalgia, Chronic Fatigue Syndrome, and Multiple Chemical Sensitivity: Illness Experiences. 

AÑO 2018

• Aguilar-Aguilar, E., Marcos-Pasero, H., de la Iglesia, R., Espinosa-Salinas, I., Ramírez de Molina, A., Reglero, G., & Loria-Kohen, V. (2018). “Characteristics and determinants of dietary intake and physical activity in a group of patients with multiple chemical sensitivity. Características y condicionantes de la ingesta dietética y actividad física en un grupo de pacientes diagnosticados de sensibilidad química múltiple”.Endocrinología, diabetes y nutrición, 65(10), 564–570.
• Gerencia Asistencial de Atención Hospitalaria, Consejería de Sanidad Comunidad de Madrid. (2018). “Protocolo de Sensibilidad Química Múltiple en las Unidades de Urgencias Hospitalaria”. Dirección General de Coordinación de la Asistencia Sanitaria. Consejería de Sanidad. Comunidad de Madrid.
• Hojo, S., Mizukoshi, A., Azuma, K., Okumura, J., Ishikawa, S., Miyata, M., Mizuki, M., Ogura, H., & Sakabe, K. (2018). “Survey on changes in subjective symptoms, onset/trigger factors, allergic diseases, and chemical exposures in the past decade of Japanese patients with multiple chemical sensitivity”.International journal of hygiene and environmental health, 221(8), 1085–1096.
• Instituto Nacional de Seguridad y Salud en el Trabajo – INSST, O.A., M.P. (2018). “Enciclopedia práctica de Medicina del Trabajo”. Ministerio de Trabajo, Migraciones y Seguridad Social.
• Rea, W.J.” A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin”. Ther. 2018, 40, 889–893.
• Steinemann A. (2018). “Prevalence and effects of multiple chemical sensitivities in Australia”. Preventive medicine reports, 10, 191–194.
• Steinemann, A. (2018). “National Prevalence and Effects of Multiple Chemical Sensitivities”. Journal of Occupational and Environmental Medicine: March 2018 – Volume 60 – Issue 3 – p e152–e156.

AÑO 2017

• Meggs,W.J. “The Role of Neurogenic Inflammation in Chemical Sensitivity”. Ecopsychology 2017, 9, 83–89.

AÑO 2016

• Manuela Lacida Baro, Benita Ardoz Flamarique, Maximiliano Bolivar Ruano, María José Gómez-Plana Usero, Manuela Márquea Ferrando, Manuel Martínez Mora, Teresa Reyes Malia. (2016). “Protocolo de Mejora de Atención a las personas con Sensibilidad Química Múltiple”. Editora/maquetadora: Lidia McHugh S.A.C. Distrito A.P. Bahía de Cádia – La Janda. Servicio Andaluz de Salud. Consejería de Salud.

AÑO 2015

• Belpomme, D., Campagnac, C., & Irigaray, P. (2015). “Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder”. Reviews on environmental health, 30(4), 251–271.
• De Luca, C., Gugliandolo, A., Calabrò, C., Currò, M., Ientile, R., Raskovic, D., Korkina, L., & Caccamo, D. (2015). “Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances”. Mediators of inflammation, 2015, 245308.
• French National Assembly (2015). “LAW PROJECT orientation and programming for the refoundation of the school of the Republic”. French Parliamentary documents, January 29 2015.
• International Scientific. (2015). “2015, Brussels International Scientific Declaration
  on Electromagnetic Hypersensitivity and Multiple Chemical Sensitivity”. International Scientific Declaration on EHS & MCS Brussels 2015.
• Sage C. (2015). “The implications of non-linear biological oscillations on human electrophysiology for electrohypersensitivity (EHS) and multiple chemical sensitivity (MCS)”. Reviews on environmental health, 30(4), 293–303.
• Valderrama Rodríguez M, Revilla López MC, Blas Diez MP, Vázquez Fernández del Pozo S, Martín Sánchez JI. (2015). “Actualización de la Evidencia Científica sobre Sensibilidad Química Múltiple (SQM)”. Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto Aragonés de Ciencias de la Salud; 2015. Informes de Evaluación de Tecnologías Sanitarias. IACS.
• World Health Organization. (2015). “International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-2015”. WHO Version for 2015 (ICD-10).
• Miller CS, Prihoda TJ. 1999-2015. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. 

AÑO 2014

• I. Alobid; S. Nogué ·A. Izquierdo‑Dominguez; S. Centellas; M. Bernal‑Sprekelsen ; J. Mullol. “Multiple chemical sensitivity worsens quality of life and cognitive and sensorial features of sense of smell”. Eur Arch Otorhinolaryngol (2014) 271:3203–3208.

AÑO 2013

• Caccamo, D., Cesareo, E., Mariani, S., Raskovic, D., Ientile, R., Currò, M., Korkina, L., & De Luca, C. (2013). “Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population”. Oxidative medicine and cellular longevity, 2013, 831969.
• Cui, X., Lu, X., Hiura, M., Oda, M., Miyazaki, W., & Katoh, T. (2013). “Evaluation of genetic polymorphisms in patients with multiple chemical sensitivity”. PloS one, 8(8), e73708.
• French National Assembly (2013). “LAW PROJECT orientation and programming for the refoundation of the school of the Republic”. French Parliamentary documents, March 2013.
• Genuis S. J. (2013). “Chemical sensitivity: pathophysiology or pathopsychology?”. Clinical therapeutics, 35(5), 572–577.
• Martini, A., Iavicoli, S., & Corso, L. (2013). “Multiple chemical sensitivity and the workplace: current position and need for an occupational health surveillance protocol”.Oxidative medicine and cellular longevity, 2013, 351457.
• Mena, G., Sequera, V. G., Nogué-Xarau, S., Ríos, J., Bertran, M. J., & Trilla, A. (2013). “Traducción y adaptación transcultural del cuestionario Quick Environmental Exposure and Sensitivity Inventory a la población española [Translation and cross-cultural adaptation of the Quick Environmental Exposure and Sensitivity Inventory for use in the Spanish population]”.Medicina clinica, 140(7), 302–304.
• Pigatto, P. D., Minoia, C., Ronchi, A., Brambilla, L., Ferrucci, S. M., Spadari, F., Passoni, M., Somalvico, F., Bombeccari, G. P., & Guzzi, G. (2013). “Allergological and toxicological aspects in a multiple chemical sensitivity cohort”. Oxidative medicine and cellular longevity, 2013, 356235.
• Valacchi, G., Caccamo, D., Pelle, E., & De Luca, C. (2013). “Innovative approaches in environmental medicine: redox/detoxification biomarkers in environmental intolerances”. Oxidative medicine and cellular longevity, 2013, 691624.

AÑO 2012

• Austrian Medical Association’s EMF Working Group. (2012). “Guideline of the Austrian Medical Association for the diagnosis and treatment of EMFrelated health problems and illnesses (EMF syndrome)“. Consensus paper of the Austrian Medical Association’s EMF Working Group – Traducción a español: Servicio de Información sobre Sensibilidad Química Múltiple y Salud Ambiental –  antes “Mi Estrella de Mar”.
• D. A. Katerndahl, I. R. Bell, R. F. Palmer, and C. S. Miller, “Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes,” The Annals of Family Medicine, vol. 10, pp. 357–365, 2012.
• Von Baehr V. (2012). “Rational Laboratory Diagnostics in Chronic. “Rationelle Labordiagnostik bei chronisch entzündlichen Systemerkrankungen”. Umwelt medizin gesellschaft 2012; 25(4): 244–7.

AÑO 2011

• De Luca, C., Raskovic, D., Pacifico, V., Thai, J. C., & Korkina, L. (2011). “The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances”. International journal of environmental research and public health, 8(7), 2770–2797.
• Donnay, A. and G. Ziem. 2011. “Prevalence and overlap of chronic fatigue syndrome and fibromyalgia syndrome among 100 new patients with multiple chemical sensitivity syndrome.” J Chronic Fatigue Syndrome 5:71-80.
• Hooper Malcom. (2011). “Psychiatry an Evidence Based Text. Basant K Puri and Ian Treasaden”. Chapter 50: Multiple Chemical Sensitivity.
• Marshall, L; Bested, A; Molot J; Kerr, K; Bray, R. (2011). “Environmental Sensitivities-Multiple Chemical Sensitivities-Status Report. Advances in Knowledga, and current service gaps”. Environmental Health Clinic. Women’s College Hospital, Toronto. Updated February 17, June 2, 2011.
• Ministerio de Sanidad, Política Social e Igualdad. (2011). “Documento de Consenso SQM”. Ministerio de Sanidad, Política Social e Igualdad.

AÑO 2010

• De Luca, C., Scordo, G., Cesareo, E., Raskovic, D., Genovesi, G., & Korkina, L. (2010). “Idiopathic environmental intolerances (IEI): from molecular epidemiology to molecular medicine”. Indian journal of experimental biology, 48(7), 625–635.
• De Luca, C., Scordo, M. G., Cesareo, E., Pastore, S., Mariani, S., Maiani, G., Stancato, A., Loreti, B., Valacchi, G., Lubrano, C., Raskovic, D., De Padova, L., Genovesi, G., & Korkina, L. G. (2010). “Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes”. Toxicology and applied pharmacology, 248(3), 285–292.
• Gilbert, S. G., Miller, E., Martin, J., & Abulafia, L. (2010). “Scientific and policy statements on environmental agents associated with neurodevelopmental disorders”. Journal of intellectual & developmental disability, 35(2), 121–128.
• Lavergne, M. R., Cole, D. C., Kerr, K., & Marshall, L. M. (2010). “Functional impairment in chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivity”. Canadian family physician Medecin de famille canadien, 56(2), e57–e65.

AÑO 2009

• Estrada MD. (2009). “Hipersensibilidad química múltiple: estado de conocimiento de la etiología y el tratamiento”. Agència d’Avaluació de Tecnologia i Recerca Mèdiques. Servei Català de la Salut. Departament de Salut. Generalitat de Catalunya; 2009.
• Johansson, Olle. (2009). “The London resolution, 2007”. Pathophysiology 16 (2009) 247–248.
• Martin L. Pall PhD. (2009). “Multiple Chemical Sensitivity: Toxicological Questions and Mechanisms: General and applied Toxicology. VI Volum, Chapter 92”. General, Applied and Systems Toxicology. Environmental and Ecotoxicology. Bryan Ballantyne (Editor), Timothy C. Marrs (Editor), Tore Syversen (Editor).
• Orriols, R., Costa, R., Cuberas, G., Jacas, C., Castell, J., & Sunyer, J. (2009). “Brain dysfunction in multiple chemical sensitivity”. Journal of the neurological sciences, 287(1-2), 72–78.
• Pall M. (2009). “General and applied Toxicology. Volum VI”. Chapter 92: Multiple Chemical Sensitivity: Toxicological Questions and Mechanisms. Bryan Ballantyne (Editor), Timothy C. Marrs (Editor), Tore Syversen (Editor).

AÑO 2008

• Bornschein, S., Hausteiner, C., Pohl, C., Jahn, T., Angerer, J., Foerstl, H., & Zilker, T. (2008). “Pest controllers: a high-risk group for Multiple Chemical Sensitivity (MCS)?”. Clinical toxicology (Philadelphia, Pa.), 46(3), 193–200.
• Cory-Slechta, D. A., Virgolini, M. B., Rossi-George, A., Thiruchelvam, M., Lisek, R., & Weston, D. (2008). “Lifetime consequences of combined maternal lead and stress”. Basic & clinical pharmacology & toxicology, 102(2), 218–227.
• Genuis S. J. (2008). “Medical practice and community health care in the 21st century: a time of change”. Public health, 122(7), 671–680.
• Goudsmit, E and Howes, S. (2008). “Is multiple chemical sensitivity a learned response? A critical evaluation of provocation studies”. Journal of Nutritional & Environmental Medicine, Volume 17, Number 3, 2008, pp. 195-211(17).
• Nowak-Wegrzyn, A., & Sicherer, S. H. (2008). “Immunotherapy for food and latex allergy”. Clinical allergy and immunology, 21, 429–446. eBook ISBN9780429136849.
• Wiesmuller GA, Niggemann H, Weissbach W, et al. (2008). “Sequence variations in subjects with selfreported multiple chemical sensitivity(sMCS): a casecontrolled study”. Journal of Toxicology and Environmental Health. Part A 71: 786–94.
• Yunus M. B. (2008). “Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness”. Seminars in arthritis and rheumatism, 37(6), 339–352.

AÑO 2007

• Brown, M. M., & Jason, L. A. (2007). “Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia”.Dynamic medicine : DM, 6, 6.
• Pall M. L. (2007). “Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle”. Medical hypotheses, 69(4), 821–825.
• Pall, M. (2007). “Explaining Unexplained Illnesses: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, Gulf War Syndrome and Others (1st ed.)”. CRC Press.
• Pall, M. L., & Bedient, S. A. (2007). “The NO/ONOO- cycle as the etiological mechanism of tinnitus”. The international tinnitus journal, 13(2), 99–104.
• Schnakenberg, E., Fabig, K. R., Stanulla, M., Strobl, N., Lustig, M., Fabig, N. and Schloot, W. (2007). “A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.” Environmental Health, 6, 6–16.

AÑO 2006

• DeRosa C.T., Hicks H.E., Ashizawa A.E., Pohl H.R., Mumtaz M.M. 2006.”A regional approach to assess the impact of living in a chemical world”. Annals of the New York Academy of Sciences 1076:829-38.
• Pall, M. L. (2006). “The NO/ONOO- cycle as the cause of fibromyalgia and related illnesses: etiology, explanation and effective therapy”. In Pederson, J. A. (Ed.), New Research in Fibromyalgia. Nova Science Publishers, Inc., Hauppauge, pp. 39–59.
• Zibrowski, E. M., & Robertson, J. M. (2006). “Olfactory sensitivity in medical laboratory workers occupationally exposed to organic solvent mixtures”. Occupational medicine (Oxford, England), 56(1), 51–54.

AÑO 2005

• Bradberry, S. M., Cage, S. A., Proudfoot, A. T. and Vale, J. A. (2005).” Poisoning due to pyrethroids”. Toxicological Reviews, 24, 93–106.
• EMF-team Finland. (2005). “Helsinki Appeal 2005”. Web Dr Magda Havas, PhD.
• Hausteiner, C., Bornschein, S., Hansen, J., Zilker, T., & Förstl, H. (2005). “Self-reported chemical sensitivity in Germany: a population-based survey”. International journal of hygiene and environmental health, 208(4), 271–278.
• Joffres, M. R., Sampalli, T., & Fox, R. A. (2005). “Physiologic and symptomatic responses to low-level substances in individuals with and without chemical sensitivities: a randomized controlled blinded pilot booth study”. Environmental health perspectives, 113(9), 1178–1183.
• Lacour, M., Zunder, T., Schmidtke, K., Vaith, P., & Scheidt, C. (2005). “Multiple chemical sensitivity syndrome (MCS)–suggestions for an extension of the U.S. MCS-case definition”. International journal of hygiene and environmental health, 208(3), 141–151.
• Latini, G., Passerini, G., Cocci-Grifoni, R. and Mariani, M. M. (2005). “Multiple chemical sensitivity as a result of exposure to heterogeneous air pollutants”. Environmental Exposure and Health, 85, 65–70.
• Ortega Pérez A. (2005). “Sensibilidad a múltiples compuestos, una enfermedad comúnmente inadvertida [Multiple chemical sensitivity, a disease commonly missed]”. Medicina clinica, 125(7), 257–262.
• Proudfoot, A. T. (2005). ” Poisoning due to pyrethrins.” Toxicological Reviews, 24, 107–113.
• Saito M, Kumano H, Yoshiuchi K, Kokubo N, Ohashi K, Yamamoto Y, Shinohara N, Yanagisawa Y, Sakabe K, Miyata M, Ishikawa S, Kuboki T. (2005). “Symptom profile of multiple chemical sensitivity in actual life”. Psychosomatic Medicine, 01 Mar 2005, 67(2):318-325.

AÑO 2004

• Caress, S. M., & Steinemann, A. C. (2004). ”Prevalence of multiple chemical sensitivities: a population-based study in the southeastern United States”. American journal of public health, 94(5), 746–747.
• Kimata H. (2004). “Effect of exposure to volatile organic compounds on plasma levels of neuropeptides, nerve growth factor and histamine in patients with self-reported multiple chemical sensitivity”. International journal of hygiene and environmental health, 207(2), 159–163.
• McKeown-Eyssen, G., Baines, C., Cole, D. E., Riley, N., Tyndale, R. F., Marshall, L., & Jazmaji, V. (2004). “Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR”.International journal of epidemiology, 33(5), 971–978.
• Pall, M. L., & Anderson, J. H. (2004). “The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity”. Archives of environmental health, 59(7), 363–375.
• Pritchard, C., Baldwin, D., & Mayers, A. (2004). “Changing patterns of adult (45-74 years) neurological deaths in the major Western world countries 1979-1997”. Public health, 118(4), 268–283.
• Yu, I. T., Lee, N. L., Zhang, X. H., Chen, W. Q., Lam, Y. T., & Wong, T. W. (2004). “Occupational exposure to mixtures of organic solvents increases the risk of neurological symptoms among printing workers in Hong Kong”. Journal of occupational and environmental medicine, 46(4), 323–330.

AÑO 2003

• Caress, S. M., & Steinemann, A. C. (2003). “A review of a two-phase population study of multiple chemical sensitivities”. Environmental health perspectives, 111(12), 1490–1497.
• Gibson, P. R., Elms, A. N., & Ruding, L. A. (2003). “Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity”. Environmental health perspectives, 111(12), 1498–1504.
• Kilburn K. H. (2003). “Effects of hydrogen sulfide on neurobehavioral function”. Southern medical journal, 96(7), 639–646.
• Mackness, B., Durrington, P., Povey, A., Thomson, S., Dippnall, M., Mackness, M., Smith, T., & Cherry, N. (2003). “Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep”. Pharmacogenetics, 13(2), 81–88.
• Pall M. L. (2003). “Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: central role of N-methyl-D-aspartate receptors in the sensitivity mechanism”. Environmental health perspectives, 111(12), 1461–1464.
• Pershall K. E. (2003). “Contact and chemical sensitivities in the hospital environment”.Otolaryngologic clinics of North America, 36(5), 1021–1034.
• Sénéchal, S., de Nadai, P., Ralainirina, N., Scherpereel, A., Vorng, H., Lassalle, P., Tonnel, A. B., Tsicopoulos, A., & Wallaert, B. (2003). “Effect of diesel on chemokines and chemokine receptors involved in helper T cell type 1/type 2 recruitment in patients with asthma”. American journal of respiratory and critical care medicine, 168(2), 215–221.
• Wu, A. and Liu, Y. (2003).”Prolonged expression of c-Fos and c-Jun in the cerebral cortex of rats after deltamethrin treatment.” Brain Research: Molecular Brain Research, 110, 147–151.

AÑO 2002

• Caress, S. M., Steinemann, A. C., & Waddick, C. (2002). “Symptomatology and etiology of multiple chemical sensitivities in the southeastern United States”. Archives of environmental health, 57(5), 429–436.
• Greene, G. J., & Kipen, H. M. (2002). “The vomeronasal organ and chemical sensitivity: a hypothesis”.Environmental health perspectives, 110 Suppl 4(Suppl 4), 655–661.
• Ma, M. K., Woo, M. H., & McLeod, H. L. (2002). “Genetic basis of drug metabolism”. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 59(21), 2061–2069.
• Pall M. L. (2002). “NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organicsolvents as the mechanism of chemical sensitivity in multiple chemical sensitivity”.FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 16(11), 1407–1417.

AÑO 2001

• Ann McCampbell, MD Co-Chair, Multiple Chemical Sensitivities Task Force of New Mexico. (2001). “MULTIPLE CHEMICAL SENSITIVITIES UNDER SIEGE”. Published in Townsend Letter for Doctors and Patients, January 2001, Issue #210, (www.townsendletter.com). http://annmccampbell.com/publicationswritings/publication-1/
• Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (2001). “Sensitization studies in chemically intolerant individuals: implications for individual difference research”. Annals of the New York Academy of Sciences, 933, 38–47.
• Binkley, K., King, N., Poonai, N., Seeman, P., Ulpian, C., & Kennedy, J. (2001). “Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7”. The Journal of allergy and clinical immunology, 107(5), 887–890.
• Brent J. (2001). “Toxicologists and the assessment of risk: the problem with mercury (commentary)”.Journal of toxicology. Clinical toxicology, 39(7), 707–710.
• Heuser, G., & Wu, J. C. (2001). “Deep subcortical (including limbic) hypermetabolism in patients with chemical intolerance: human PET studies”. Annals of the New York Academy of Sciences, 933, 319–322. https://doi.org/10.1111/j.1749-6632.2001.tb05835.x
• Kutsogiannis, D. J., & Davidoff, A. L. (2001). “A multiple center study of multiple chemical sensitivity syndrome”. Archives of environmental health, 56(3), 196–207″.
• LoVecchio, F., & Fulton, S. E. (2001). “Ventricular fibrillation following inhalation of Glade Air Freshener”. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 8(2), 153–154.
• McKeown-Eyssen, G. E., Baines, C. J., Marshall, L. M., Jazmaji, V. and Sokoloff, E. R. (2001). “Multiple chemical sensitivity: discriminant validity of case definitions.” Archives of Environmental Health, 56(5), 406–412.
• MacPhail R.C. (2001). ”Episodic exposures to chemicals: What relevance to chemical intolerance?”. Annals of the New York Academy of Sciences 933, 103-11.
• Miller C. S. (2001). “The compelling anomaly of chemical intolerance”. Annals of the New York Academy of Sciences, 933, 1–23.
• Pall M.L. (2001). “Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite”. Medical Hypotheses 57(2): 139-45.

AÑO 2000

• Davidoff, A. L., Fogarty, L., & Keyl, P. M. (2000). “Psychiatric inferences from data on psychologic/psychiatric symptoms in multiple chemical sensitivities syndrome”. Archives of environmental health, 55(3), 165–175.
• Donnay, A. (2000). “Carbon monoxide as an unrecognized cause of neurasthenia: a history”. In Penney, D. (Ed.), Carbon Monoxide Toxicity. CRC Press, Boca Raton, pp. 231–260. Published 2 June 2000.
• Haley, R. W., Marshall, W. W., McDonald, G. G., Daugherty, M. A., Petty, F., & Fleckenstein, J. L. (2000). “Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy”. Radiology, 215(3), 807–817.
• Miller, C. S. (2000). “Mechanisms of action of addictive stimuli”. Addiction (2000), 96(1), 115–139.
• Nebert D. W. (2000). “Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants”. Clinical chemistry and laboratory medicine, 38(9), 857–861.

AÑO 1999

• Anderson R.C., Anderson J.H. (1999). “Sensory irritation and multiple chemical sensitivity”. Toxicology and Industrial Health 15(3-4): 339-45.
• Ashford N. A. (1999). “Low-level chemical sensitivity: implications for research and social policy”. Toxicology and industrial health, 15(3-4), 421–427.
• Ashford, Nicholas A.; Miller, Claudia S. (1999). “Chemical Exposures- Low Levels and High Stakes, 2nd Edition”. J. Chem. Educ. 1999, 76, 7, 903. Publication Date:July 1, 1999.
• Bartha, L. (1999). “Multiple chemical sensitivity: A 1999 consensus”. Archives of Environmental Health: An International Journal, 54(3):147–149.
• Bell, I. R., Baldwin, C. M., Fernandez, M. and Schwartz, G. E. (1999). “Neural sensitization model for multiple chemical sensitivity: overview of theory and empirical evidence”. Toxicology and Industrial Health, 15 (3-4), 295–304.
• Bell, I. R., Szarek, M. J., Dicenso, D. R., Baldwin, C. M., Schwartz, G. E. and Bootzin, R. R. (1999b). “Patterns of waking EEG spectral power in chemically intolerant individuals during repeated chemical exposures”. The International Journal of Neuroscience, 97, 41–59.
• Brown-DeGagne A.M., McGlone J. (1999). “Multiple chemical sensitivity: a test of the olfactory-limbic model”. Journal of Occupational and Environmental Medicine 41(5): 366-77
• Donay, A.(1999). “On the Recognition of Multiple Chemical Sensitivity in Medical Literature and Government Policy”. International Jornal of Toxicology. First Published November 1, 1999.
• Fernandez, M., Bell, I. R., & Schwartz, G. E. (1999). “EEG sensitization during chemical exposure in women with and without chemical sensitivity of unknown etiology”. Toxicology and industrial health, 15(3-4), 305–312.
• Haley, R. W., Billecke, S., & La Du, B. N. (1999). “Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans”. Toxicology and applied pharmacology, 157(3), 227–233.
• Haley, R. W., Billecke, S., & La Du, B. N. (1999). “Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans”.Toxicology and applied pharmacology, 157(3), 227–233.
• Kilburn K.H. (1999). ”Measuring the effects of chemicals in the brain.” Archives of Environmental Health 54(3): 150.
• Miller, C.S. (1999a). ”Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction”. Toxicol Ind Health 15:284-294.
• Miller, C.S. and T.J. Prihoda. (1999b). ”A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity”. Toxicol Ind Health 15:386-397.
• Miller C.S. and Prihoda T.J. (1999c). “The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications”. Toxicology and Industrial Health 15(3/4): 370-85.
• Miller, C.S., R.B. Gammage, and J.T. Jankovic. (1999d). “Exacerbation of chemical sensitivity: a case study.” Toxicol Ind Health 15:398-402.
• Ross, G. H., Rea, W. J., Johnson, A. R., Hickey, D. C. and Simon, T. R. (1999). “Neurotoxicity in single photon emission computed tomography brain scans of patients reporting chemical sensitivities”. Toxicology and Industrial Health, 15, 415–420.
• Sorg, B.A. (1999). “Multiple Chemical Sensitivity: potential role of neural sensitization”. Critical Reviews in Neurobiology, 13. 283-316.
• Ziem GE. (1999). “Profile of patients with chemical injury and sensitivity, Part II”. International Journal of Toxicology 1999:18: 401-409.

AÑO 1998

• Baldwin C.M. and Bell I.R. (1998). “Increased cardiopulmonary disease risk in a community-based sample with chemical odor intolerance: implications for women’s health and health-care utilization”. Archives of Environmental Health 1998 53(5): 347-53.
• Bell I.R., Warg-Damiani L., Baldwin C.M., Walsh M.E., Schwartz G.E. (1998). “Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings”. Military Medicine 163(11): 725-32.
• Davidoff, A.L., P.M. Keyl, and W.J. Meggs. (1998).” Development of multiple chemical sensitivities in laborers after acute gasoline fume exposure in an underground tunneling operation”. Arch Environ Health 53:183-189
• Lieberman A.D., Craven M.R. (1998). “Reactive Intestinal Dysfunction Syndrome (RIDS) caused by chemical exposures”. Archives of Environmental Health 53(5): 354-58.

AÑO 1997

• Bascom R., Meggs W.J., Framptom M., Hudnell K., Kilburn K., Kobal G., Medinsky M., Rea W. (1997). “Neurogenic inflammation: with additional discussion of central and perceptual integration of nonneurogenic inflammation.” Environmental Health Perspective 105 (Suppl. 2): 531-37.
• Fincher, C. E., Chang, T. S., Harrell, E. H., Kettelhut, M. C., Rea, W. J., Johnson, A., Hickey, D. C., & Simon, T. R. (1997). “Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults”. American journal of industrial medicine, 31(1), 4–14.
• Fincher, C. E., Chang, T. S., Harrell, E. H., Kettelhut, M. C., Rea, W. J., Johnson, A., Hickey, D. C., & Simon, T. R. (1997). “Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults: correction of previous results”. American journal of industrial medicine, 32(6), 693–694.
• Ignatova, M.S., E.A. Kharina, V.A. Spitsin, V.V. Dlin, E.A. Iur’eva, I.M. Osmanov, and G.P. Raba. (1997).” [Ecopathology of the kidneys and individual sensitivity to heavy metal salts]”.  Ter Arkh 69:44-49.
• Kawamoto, M. M., Esswein, E. J., Wallingford, K. M. and Worthington, K. A. (1997). “NIOSH Health Hazard Evaluation Report. HETA 96-0012-2652”. Health Hazard Evaluation Report No. 96-0012. Brigham and Women’s Hospital, Boston, U. S. Department of Health and Human Services, Washington, DC.
• Kilburn K. H. (1997). “Exposure to reduced sulfur gases impairs neurobehavioral function”. Southern medical journal, 90(10), 997–1006.
• Miller C. S. (1997). “Toxicant-induced loss of tolerance–an emerging theory of disease?”. Environmental health perspectives, 105 Suppl 2(Suppl 2), 445–453.
• Miller C., Ashford N., Doty R., Lamielle M. Otto D., Rahill A., Wallace L. (1997). “Empirical approaches for the investigation of toxicant-induced loss of tolerance.” Environmental Health Perspectives 102 (Suppl 2): 515-19.
• Rea, W. J. (1997). “Chemical Sensitivity: Tools of Diagnosis and Methods of Treatment, Vol. 4”. Lewis Publishers, Boca Raton, Florida..
• Ross, G.H. (1997).” Clinical characteristics of chemical sensitivity: an illustrative case history of asthma and MCS”. Environ Health Perspect 105:437-431.
• Sorg, B. A. and Prasad, B. M. (1997). “Potential role of stress and sensitization in the development and expression of multiple chemical sensitivity”. Environmental Health Perspectives, 105, 467–471.
• Ziem, G., & McTamney, J. (1997). “Profile of patients with chemical injury and sensitivity”. Environmental health perspectives, 105 Suppl 2(Suppl 2), 417–436.

AÑO 1996

• Bell I.R., Schwartz G.E., Baldwin C.M., Hardin E.E. (1996).” Neural sensitization and physiological markers in multiple chemical sensitivity”. Regulatory Toxicology and Pharmacology 24(1), pt. 2: S39-47.
• Davidoff, A.L. and P.M. Keyl. (1996). “Symptoms and health status in individuals with multiple chemical sensitivities syndrome from four reported sensitizing exposures and a general population comparison group”. Arch Environ Health 51:201-213.
• Gammage, R., Miller, C. S., and Jankovic, J. (1996). “Exacerbation of chemical sensitivity associated with new construction: a case study.” 2 (Tuesday), 291-296. “The 7th International Conference on Indoor Air Quality and Climate. Indoor Air” ’96, July 21-26, Nagoya Japan.
• Gibson, P.R., J. Cheavens, and M.L. Warren. (1996). “Chemical Sensitivity/Chemical Injury and Life Disruption”. Women & Therapy 19:63-79.
• McFadden, S.A. (1996). ”Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways”. Toxicology 111:43-6
• Meggs W.J., Dunn K.A., Bloch R.M., Goodman P.E., Davidoff A.L. (1996). “Prevalence and nature of allergy and chemical sensitivity in a general population”. Archives of Environmental Health 51(4): 275-82.
• Miller, C.S. (1996). “Chemical sensitivity: symptom, syndrome or mechanism for disease?“. Toxicology 111:69-86.
• Rea, W. J. (1996). “Chemical Sensitivity, Vol. 3”. Lewis Publishers, Boca Raton, Florida.
• Rea, William J., Pan, Y. (1996). “Fat and Blood Levels of Toxic Chemicals in Chemically Sensitive Patients”. Journal of Nutritional and Environmental Medicine, United Kingdom, London, issue 5,387-390, March 1996.
• Rossi, J. III (1996). “Sensitization induced by kindling and kindling-related phenomena as a model for Multiple Chemical Sensitivity”. Toxicology, Volume 111, Issues 1–3, 17 July 1996, Pages 87-100.

AÑO 1995

• Ashford, N., Heinzow, B., Lütjen, K., Marouli, C., Mølhave, L., Mönch, B., … & Velonakis, E. (1995). “Chemical sensitivity in selected European countries: an exploratory study”. A report to the European Commission. Ergonomia, Athens, Greece.
• Miller C.S. and Mitzel H.C. (1995). “Chemical sensitivity attributed to pesticide exposure versus remodeling”. Archives of Environmental Health 50(2): 119-29.
• Meggs W. J. (1995). “Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity”. Environmental health perspectives, 103(1), 54–56.
• Muttray, A., Lang, J., Mayer-Popken, O., & Konietzko, J. (1995). “Acute changes in the EEG of workers exposed to mixtures of organic solvents”. International journal of occupational medicine and environmental health, 8(2), 131–137.
• Narahashi, T., Carter, D. B., Frey, J., Ginsburg, K., Hamilton, B. J., Nagata, K., Roy, M. L., Song, J. H. and Tatebayashi, H. (1995). “Sodium channels and GABA receptor-channel complex as targets of environmental toxicants”. Toxicology Letters, 82–83, 239–245.

AÑO 1994

• Buchwald D., Garrity D. (1994). “Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities.” Archives of Internal Medicine 154(18): 2049-53.
• Antelman, S. M. (1994). “Time-Dependent Sensitization in Animals: A Possible Model of Multiple Chemical Sensitivity in Humans”. Toxicology and Industrial Health. 1994;10(4-5):335-342.
• Davidoff, A. L., & Fogarty, L. (1994). “Psychogenic origins of multiple chemical sensitivities syndrome: a critical review of the research literature”. Archives of environmental health, 49(5), 316–325.
• Friedman M. J. (1994). “Neurobiological sensitization models of post-traumatic stress disorder: their possible relevance to multiple chemical sensitivity syndrome”. Toxicology and industrial health, 10(4-5), 449–462.
• Heuser, G., Mena, I., & Alamos, F. (1994). “NeuroSPECT findings in patients exposed to neurotoxic chemicals”. Toxicology and industrial health, 10(4-5), 561–571.
• Lorig, T. S. (1994). “EEG and ERP studies of low-level odor exposure in normal subjects”. Toxicology and Industrial Health, 10, 579–586.
• Montgomery, M.R. and M.J. Reasor. (1994). ”A toxicologic approach for evaluating cases of sick building syndrome or multiple chemical sensitivity”.  J Allergy Clin Immunol 94:371-375.
• Romano TJ, Stiller JW. (1994). “Magensium Deficiency in Fibromyalgia Syndrome”. Journal of Nutritional Medicine 1994; Vol. 4, Issue 2, pages 165-167.
• Schwartz, G. E., Bell, I. R., Dikman, Z. V., Fernandez, M., Kline, J. P., Peterson, J. M. and Wright, K. P. (1994). ” EEG responses to low-level chemicals in normals and cacosmics”. Toxicology and Industrial Health, 10, 633–643.
• Simon, T. R., Hickey, D. C., Fincher, C. E., Johnson, A. R., Ross, G. H. and Rea, W. J. (1994). “Single photon emission computed tomography of the brain in patients with chemical sensitivities”. Toxicology and Industrial Health, 10, 573–577.

AÑO 1993

• Ashford, N.A. and C.S. Miller. (1993). “Mulitple chemical sensitivity”. Health Env.Digest 6:11
• Bell, I.R.; Schwartz, G.E.; Peterson, J.M.; Amend, D. (1993a). “Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures.” Environ. Health 48, 6–13.
• Bell, I.R.; Schwartz, G.E.; Peterson, J.M.; Amend, D.; Stini,W.A. (1993b). “Possible time-dependent sensitization to xenobiotics: Self-reported illness from chemical odors, foods, and opiate drugs in an older adult population”. Environ. Health 48, 315–327.
• Gibson, P. (1993). “Environmental Illness/Multiple Chemical Sensitivities: Invisible Disabilities”. Women and Therapy 14:171-185.
• Meggs W. J. (1993). “Neurogenic inflammation and sensitivity to environmental chemicals”. Environmental health perspectives, 101(3), 234–238.
• Meggs W.J., Cleveland C.H. Jr. (1993). “Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome”. Archives of Environmental Health 48(1): 14-18.

AÑO 1992

• Bell, I. R., Miller, C. S., & Schwartz, G. E. (1992). “An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders”. Biological psychiatry, 32(3), 218–242.
• Davidoff, L.L. (1992). “Models of multiple chemical sensitivities (MCS) syndrome: using empirical data (especially interview data) to focus investigations”. Ind.Health 8:229-247.
• Heuser, G., A. Wodjani, and S. Heuser. (1992). “Diagnostic markers in chemical sensitivity. In Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology”. AnonymousNational Academy Press, Washington DC. 117-138.
• Maschewsky, W. (1992). “Brain damage by workplace chemicals – overdiagnosis or underreporting?”. J.Health.Sci. 3:105-110.
• Meggs, W.J. (1992a). ”Multiple chemical sensitivities and the immune system”. [Review]. Toxicol.Ind.Health 8:203-214.
• Meggs, W.J. (1992b). “Immunological Mechanisms of Disease and the Multiple Chemical Sensitivity Syndrome. In Multiple Chemical Sensitivities: Addendum to Biological Markers in Immunotoxicology”. AnonymousNational Academy Press, Washington, D.C. 155-169.
• Rea, W.J. (1992). “Chemical Sensitivity, Vo.l 1”. Lewis Publishers, Boca Raton, Florida.
• Ross, G.H. (1992). “Treatment options in multiple chemical sensitivity”. Toxicol.Ind.Health 8:87-94.
• Ziem. (1992a). “Multiple chemical sensitivity: treatment and followup with avoidance and control of chemical exposures”. Toxicology and Industrial Health, vol. 8, no. 4, pp. 73–86.
• Ziem, G.E. and L.L. Davidoff. (1992b). “Illness from chemical “odors”: is the health significance understood?” [editorial; comment] [see comments]. Arch.Environ.Health 47:88-91

AÑO 1991

• Cox, I. M., Campbell, M. J., & Dowson, D. (1991). “Red blood cell magnesium and chronic fatigue syndrome”. Lancet (London, England), 337(8744), 757–760.
• Pan, Y., Johnson, A. R., & Rea, W. J. (1991). “Aliphatic hydrocarbon solvents in chemically sensitive patients”. Boletin de la Asociacion Medica de Puerto Rico, 83(7), 316–320.
• Rea, W.J., G.H. Ross, A.R. Johnson, R.E. Smiley, and E.J. Fenyes. (1991a). ”Chemical sensitivity in physicians“. [Review] [44 refs]. Bol Asoc Med P R 83:383-388.
• Rea, W.J. and G.H. Ross. (1991b). ”Food and chemicals as environmental incitants”. Asoc.Med.P.R. 83:310-315.
• Rogers SA, (1991). “Unrecognized Magnesium Deficiency masquerades as diverse symptoms. Evaluation of an oral magnesium challenge tests”. Intern clin nutr rev 11:3; 117-125.

AÑO 1990

• Parkinson D.K., Bromet S., Cohen L.O., Dunn M.A., Dew C. (1990). “Health effects of long-term solvent exposure among women in blue-collar occupations.” American Journal of Industrial Medicine 17(6): 661-75.
• Rogers SA. (1990). “Zinc deficiency as a model for developing chemical sensitivity”. Intern Clin Rev, 10:1, 253, Jan 1990.
• Valentine, W. M. (1990). “Toxicology of selected pesticides, drugs, and chemicals. Pyrethrin and pyrethroid insecticides.” The Veterinary Clinics of North America: Small Animal Practice, 20, 375–382.

AÑO 1989

• Davidoff, L.L. (1989). “Multiple chemical sensitivities.” The Amicus Journal Winter:13-23.
• Johnson, A. R. and Rea, W. J. (1989). “Review of 200 cases in the environmental control unit, Dallas, Presentation at the 7th International Symposium on Man and His Environment in Health and Disease”. February 25-26. Dallas, TX. 2-25.
• Rea, W.J. and G.H. Ross. (1989).” Food and chemicals as environmental incitants”. [see comments]. Nurse Pract. 14:17-8, 28, 30 passim
• Ross, G.H., Rea, W.J., Johnson, A.R., Maynard, B.J., Carlisle, L. (1989). “Evidence for Vitamin Deficiencies in Environmentally-Sensitive Patients”. Clinical Ecology, Vol. VI, No. 2, pp. 60-66, 1989.

AÑO 1988

• Rea, W.J. (1988). “Chemical hypersensitivity and the allergic response”. Nose.Throat.J 67:50-56.

AÑO 1987

• Galland, L. (1987). “Biochemical abnormalities in patients with multiple chemical sensitivities”. Med. 2:713-720.
• Rea, W.J., Pan, Yaqin, Laseter, J.L., Johnson, A.R., Fenyves, E.J.. (1987). “Toxic Volatile Organic Hydrocarbons in Chemically Sensitive Patients”. Clinical Ecology, Vol. V, No. 2.

AÑO 1986

• Iasnetsov, V.V. and V.A. Pravdivtsev. (1986). ”[Chemical sensitivity of the neurons of the medial vestibular nucleus to enkephalins, acetylcholine, GABA and L-glutamate]”. Biol.Aviakosm.Med. 20:53-57.
• Rea, W.J., Johnson, A.R., Smiley, R.E., Maynard, B., Dawkins‑Brown, O. (1986). “Magnesium Deficiency in Patients with Chemical Sensitivity”. Clinical Ecology, Vol. IV, No. 1, pp. 17‑20.

AÑO 1980

• Jakoby WB. (1980a). “Enzimatic Basis of Detoxification. Vol 1”. Academic Press. New York. 1st Edition – October 28, 1980. eBook ISBN: 9780323137980.
• Jakoby WB. (1980b). “Enzimatic Basis of Detoxification. Vol 2”. ELSEVIER.Academic Press. New York. 1st Edition October 28, 1980. eBook ISBN: 9780323138208.

AÑO 1978

• Rea, W.J., I.R. Bell, C.W. Suits, and R.E. Smiley. (1978). “Food and chemical susceptibility after environmental chemical overexposure: case histories”. Allergy 41:101-109.

AÑO 1965

• Randolph, T.G. (1965). “Ecologic orientation in medicine: comprehensive environmental control in diagnosis and therapy”. Allergy 23:7

AÑO 1962

• Randolph, T.G. (1962). “Human Ecology and Susceptibility to the Chemical Environment”.C.Thomas, Springfield,IL.

AÑO 1956

• Randolph, T.G. (1956). ”The specific adaptation syndrome”. Lab.Clin.Med 48:934-941.

AÑO 1955

• Randolph, T.G. (1955).”Depressions caused by home exposures to gas and combustion products of gas, oil, and coal”. Lab.Clin.Med 46:942

AÑO 1954

• Randolph, T.G. (1954a). “Allergic type reactions to motor exhaust”. Lab.Clin.Med 44:912
• Randolph, T.G. (1954b). “Allergic type reactions to indoor utility gas and oil fumes” Lab.Clin.Med 44:913
• Randolph, T.G. (1954c). “Allergic type reactions to chemical additives of foods and drugs” Lab.Clin.Med 44:913-914.
• Randolph, T.G. (1954d). “Allergic type reactions to mosquito abatement fogs and mists.” Lab.Clin.Med 44:911-912.
• Randolph, T.G. (1954e). “Allergic type reactions to industrial solvents and liquid fuels” Lab.Clin.Med 44:910-911.

AÑO 1952

• Randolph, T.G. (1952). “Sensitivity to petroleum including its derivatives and antecedents.” Lab.Clin.Med 40:931-932.